These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29970016)

  • 1. Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.
    Patel SK; Velkoska E; Gayed D; Ramchand J; Lesmana J; Burrell LM
    BMC Nephrol; 2018 Jul; 19(1):159. PubMed ID: 29970016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.
    Burchill L; Velkoska E; Dean RG; Lew RA; Smith AI; Levidiotis V; Burrell LM
    Exp Physiol; 2008 May; 93(5):622-30. PubMed ID: 18223026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy.
    Patel SK; Ramchand J; Crocitti V; Burrell LM
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease.
    Bao J; Lu Y; She Q; Dou W; Tang R; Xu X; Zhang M; Zhu L; Zhou Q; Li H; Zhou G; Yang Z; Shi S; Liu Z; Zheng C
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33848263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
    Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
    J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts.
    Patel SK; Wai B; Lang CC; Levin D; Palmer CNA; Parry HM; Velkoska E; Harrap SB; Srivastava PM; Burrell LM
    EBioMedicine; 2017 Apr; 18():171-178. PubMed ID: 28400202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
    Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
    PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
    Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic background influences cardiac phenotype in murine chronic kidney disease.
    Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
    Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.
    Panizo S; Barrio-Vázquez S; Naves-Díaz M; Carrillo-López N; Rodríguez I; Fernández-Vázquez A; Valdivielso JM; Thadhani R; Cannata-Andía JB
    Nephrol Dial Transplant; 2013 Nov; 28(11):2735-44. PubMed ID: 24013683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte loss in experimental renal failure: prevention by ramipril.
    Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G
    Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.
    Velkoska E; Dean RG; Griggs K; Burchill L; Burrell LM
    Clin Sci (Lond); 2011 Apr; 120(8):335-45. PubMed ID: 21091432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression in uremic left ventricular hypertrophy: effects of hypertension and anemia.
    Mak RH; Chang SL; Draksharapu A; Pak YK
    Exp Mol Med; 2004 Jun; 36(3):251-8. PubMed ID: 15272237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
    Di Marco GS; Reuter S; Kentrup D; Grabner A; Amaral AP; Fobker M; Stypmann J; Pavenstädt H; Wolf M; Faul C; Brand M
    Nephrol Dial Transplant; 2014 Nov; 29(11):2028-35. PubMed ID: 24875663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
    Velkoska E; Patel SK; Griggs K; Burrell LM
    PLoS One; 2016; 11(8):e0161760. PubMed ID: 27571511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat.
    Holmer SR; Bruckschlegel G; Schunkert H; Rataj DB; Kromer EP; Riegger GA
    Cardiovasc Res; 1996 May; 31(5):719-28. PubMed ID: 8763401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity.
    Leenders JJ; Wijnen WJ; Hiller M; van der Made I; Lentink V; van Leeuwen REW; Herias V; Pokharel S; Heymans S; de Windt LJ; Høydal MA; Pinto YM; Creemers EE
    J Biol Chem; 2010 Aug; 285(35):27449-27456. PubMed ID: 20566642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts.
    Wang B; Haldar SM; Lu Y; Ibrahim OA; Fisch S; Gray S; Leask A; Jain MK
    J Mol Cell Cardiol; 2008 Aug; 45(2):193-7. PubMed ID: 18586263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF15 is an essential negative regulatory factor for the cardiac remodeling response to pressure overload.
    Yu Y; Ma J; Xiao Y; Yang Q; Kang H; Zhen J; Yu L; Chen L
    Cardiology; 2015; 130(3):143-52. PubMed ID: 25633973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.